Loading...
You are here:  Home  >  Health  >  Current News

Pfizer immuno-oncology drug wins U.S. approval for bladder cancer



(Reuters) - U.S. health regulators on Tuesday granted accelerated approval for Pfizer Inc's immuno-oncology drug Bavencio to treat advanced bladder cancer, marking the second approval in less than two months for the treatment developed along with Germany's Merck KGaA.


Other News

AstraZeneca boosts early respiratory medicine with Pieris deal LONDON (Reuters) - AstraZeneca boosted its early-stage respiratory medicine pipeline on Wednesday by signing a deal with Pieris Pharmaceuticals to d...
New heart drugs struggle to win sales as doctors hold back LONDON (Reuters) - New heart drugs hailed as breakthrough treatments by researchers are struggling to gain traction among prescribing doctors, posin...
Vitamin D levels tied to breast cancer survival (Reuters Health) - For women diagnosed with breast cancer, high vitamin D levels in the blood may be tied to better odds of surviving and having tumor...

Found news:

Loading...

You might also like...

Details on surprise Novartis heart drug success due Aug 27

Read More →